Target intelligence / Profile preview

RNA, U6 small nuclear 365, pseudogene (RNU6-365P)

Target
RNU6-365P
Molecular classification
Pseudogene, Small nuclear RNA pseudogene
01

Overview

**RNU6-365P** (RNA, U6 small nuclear 365, pseudogene) is a pseudogene related to U6 small nuclear RNA, mapping to human chromosome 1[4]. U6 snRNA belongs to a family of small nuclear non-coding RNAs that play a key role in pre-mRNA splicing, forming a core part of the spliceosome complex[3][5]. However, as a **pseudogene**, RNU6-365P is not believed to produce a functional RNA or protein; it lacks coding potential and regulatory elements necessary for normal gene function[1][2]. Pseudogenes typically arise from duplication or retrotransposition events and accumulate mutations that inactivate their function[2]. While some pseudogenes can have regulatory or disease-modifying effects, there is no evidence that RNU6-365P performs any biological roles or serves as a therapeutic target. **Is_incorrect?** - Yes. The designation "RNA, U6 small nuclear 365, pseudogene" refers to a non-coding RNA pseudogene, not a targetable macromolecule like an enzyme, receptor, transporter, or signaling protein. It is not considered a conventional drug target, and there is no evidence of it being involved in pharmacology, clinical biomarkers, or therapeutic modulation. Some pseudogenes have emerging regulatory roles or may serve as disease biomarkers, but there is no data supporting such functions for RNU6-365P[1][2][4].

Other names
RNU6-365PU6 snRNA pseudogene 365
02

Biological functions

Other (pseudogenes may have roles in gene expression regulation, but specific functions for RNU6-365P are not documented[1][4][2])
03

Disease associations

Other (some pseudogenes have been implicated as disease biomarkers, especially in cancer, but there is no evidence that RNU6-365P is involved in any specific disease[2])

Beyond the preview

Go deeper on RNA, U6 small nuclear 365, pseudogene (RNU6-365P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 365, pseudogene (RNU6-365P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call